These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 35363268)
1. Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy. Lin JX; Tang YH; Lin GJ; Ma YB; Desiderio J; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Parisi A; Truty MJ; Huang CM JAMA Netw Open; 2022 Apr; 5(4):e225557. PubMed ID: 35363268 [TBL] [Abstract][Full Text] [Related]
2. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method]. Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514 [TBL] [Abstract][Full Text] [Related]
3. Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. Sugawara T; Rodriguez Franco S; Sherman S; Kirsch MJ; Colborn K; Ishida J; Grandi S; Al-Musawi MH; Gleisner A; Schulick RD; Del Chiaro M JAMA Oncol; 2023 Mar; 9(3):316-323. PubMed ID: 36480190 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718 [TBL] [Abstract][Full Text] [Related]
5. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data]. Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769 [No Abstract] [Full Text] [Related]
6. Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study. Su P; Jiang L; Zhang Y; Yu T; Huang H; Chen M; Cao C; Kang W; Liu Y; Yu J Eur J Med Res; 2023 Oct; 28(1):409. PubMed ID: 37814327 [TBL] [Abstract][Full Text] [Related]
7. Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A. Fujitani K; Nakamura K; Mizusawa J; Kuwata T; Shimoda T; Katayama H; Kushima R; Taniguchi H; Yoshikawa T; Boku N; Terashima M; Fukuda H; Sano T; Sasako M; Gastric Cancer; 2021 Jan; 24(1):197-204. PubMed ID: 32572792 [TBL] [Abstract][Full Text] [Related]
8. Lymph node ratio is a prognostic indicator for locally advanced gastric cancer after neoadjuvant immunochemotherapy. Zhou P; Sun X; Zeng L; Zeng X; Xie G; Liu X; Tao K; Zhang P BMC Gastroenterol; 2024 Oct; 24(1):371. PubMed ID: 39427177 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG; JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170 [TBL] [Abstract][Full Text] [Related]
10. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial. Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736 [TBL] [Abstract][Full Text] [Related]
11. Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection. Polanco PM; Mokdad AA; Zhu H; Choti MA; Huerta S JAMA Oncol; 2018 Jul; 4(7):938-943. PubMed ID: 29710272 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma. Setakornnukul J; Thephamongkhol K BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage. Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475 [TBL] [Abstract][Full Text] [Related]
14. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection]. Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920 [No Abstract] [Full Text] [Related]
15. Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study. Pu N; Wu W; Liu S; Xie Y; Yin H; Chen Q; He T; Xu Z; Wang W; Yu J; Liu L; Lou W Int J Surg; 2023 Oct; 109(10):3137-3146. PubMed ID: 37418574 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer. Gbolahan OB; Zhi X; Liu Y; Shah MM; Kooby DA; Alese OB JAMA Netw Open; 2024 Jan; 7(1):e2351502. PubMed ID: 38206623 [TBL] [Abstract][Full Text] [Related]
17. Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis. Kano M; Hayano K; Hayashi H; Hanari N; Gunji H; Toyozumi T; Murakami K; Uesato M; Ota S; Matsubara H Ann Surg Oncol; 2019 Jun; 26(6):1805-1813. PubMed ID: 30977014 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and Resection. Atay SM; Amini M; Ding L; David EA; Mcfadden PM; Wightman SC; Kim AW Ann Thorac Surg; 2021 Jul; 112(1):197-205. PubMed ID: 33121965 [TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Chemotherapy Xu W; Wang L; Yan C; He C; Lu S; Ni Z; Hua Z; Zhu Z; Sah BK; Yang Z; Zheng Y; Feng R; Li C; Yao X; Chen M; Liu W; Yan M; Zhu Z Front Oncol; 2021; 11():718556. PubMed ID: 34497768 [TBL] [Abstract][Full Text] [Related]
20. Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy. Jiang Q; Zeng X; Zhang C; Yang M; Fan J; Mao G; Shen Q; Yin Y; Liu W; Tao K; Zhang P World J Surg Oncol; 2022 Aug; 20(1):261. PubMed ID: 35978363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]